ERYtech Pharma To Present At Jefferies and Co. Global Healthcare Conference
Regulatory News:
ERYTECH (Paris:ERYP) (Euronext Paris: FR0011471135 - ERYP), the French biopharmaceutical company that develops innovative ‘tumor starvation’ treatments for acute leukemia and other oncology indications with unmet medical need, will be presenting at Jefferies Global Healthcare Conference in London next week.
Help employers find you! Check out all the jobs and post your resume.
ERYTECH (Paris:ERYP) (Euronext Paris: FR0011471135 - ERYP), the French biopharmaceutical company that develops innovative ‘tumor starvation’ treatments for acute leukemia and other oncology indications with unmet medical need, will be presenting at Jefferies Global Healthcare Conference in London next week.
Help employers find you! Check out all the jobs and post your resume.